Biotech Firm Buys Maker of Late-Stage Parkinson’s Drug

25.09.2014 - US-based Acorda Therapeutics has acquired privately held Civitas Therapeutics for $525 million to gain access to a Parkinson's disease drug in late-stage development. With the buy...